{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-25-001076","form_type":"8-K","ticker":"LNAI","cik":"0001527728","company_name":"Lunai Bioworks Inc.","filed_at":"2025-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.233069+00:00","generated_at":"2026-05-17T19:22:10.721262+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Renovaro receives Nasdaq non-compliance notice for annual meeting; granted extension to Oct 31, 2025","bullets":["Received Nasdaq notice on July 7, 2025 for failure to comply with Listing Rule 5620(a) requiring annual shareholder meeting.","Nasdaq accepted compliance plan on August 5, 2025 and granted extension until October 31, 2025 to hold meeting.","Company intends to hold annual meeting within the extension period to regain compliance with listing standards."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-25-001076","json":"https://secwatch.observer/filing/0001731122-25-001076.json","markdown":"https://secwatch.observer/filing/0001731122-25-001076.md","text":"https://secwatch.observer/filing/0001731122-25-001076.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1527728/000173112225001076/0001731122-25-001076-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1527728/000173112225001076/e6758_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T19:22:10.721262+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"90c4320ed7648e2a67918d565814a44c8f068e75","claim":"Lunai Bioworks Inc. received a nasdaq deficiency notice notice regarding shareholders (rules 5620(a)).","evidence_excerpt":"July 7, 2025, Renovaro Inc. (the “Company”) received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5620(a), which requires listed companies to hold an annual meeting of shareholders within twelve months of the end of their fiscal year. On August 5, 2025, the Company received written confirmation from Nasdaq that it has accepted the Company’s plan to regain compliance and has granted an extension until October 31, 2025, for the Company to hold its annual meeting of shareholders. The Company intends to hold the ann","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112225001076/0001731122-25-001076-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"shareholders"},{"label":"Rules","value":"5620(a)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}